Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176514 · ClinicalTrials.gov registry record · NA
A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis
A NA study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00176514: Clinical Trial NA study, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00176514 is a NA study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176514, a NA study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This is a clinical research study that is designed to determine if there is a potential benefit of green tea to help treat and prevent therapy induced mucositis, which is mouth sores caused by chemotherapy.
Interventions
- DRUG Administration of the antineoplastic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2000-07 |
| Est. Completion | 2006-03 |
| Phase | NA |
Why NCT00176514 stopped before completion
NCT00176514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Administration of the antineoplastic is the first listed.
NCT00176514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00176514 about?
NCT00176514 is a clinical study titled "A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis". This is a clinical research study that is designed to determine if there is a potential benefit of green tea to help treat and prevent therapy induced mucositis, which is mouth sores caused by chemotherapy.
What is the current status of trial NCT00176514?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2000-07. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00176514?
The interventions under investigation include: Administration of the antineoplastic (DRUG).
Who is sponsoring clinical trial NCT00176514?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00176514's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia